Loading…
Lobbying Spend
—
Filings
68
Firms Hired
2
Active Period
2003–2020
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
2007 · mid_year · Firm: JEFFERSON GOVERNMENT RELATIONS, L.L.C.
H.R. 3043, Making Appropriations for the Department of Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2008, provisions related to funding HRSA and programs on organ donation. S.1710, Same title as above.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3043
William H. Frist Gift of Life Congressional Medal Act of 2007
2007 · mid_year · Firm: JEFFERSON GOVERNMENT RELATIONS, L.L.C.
3)FDA's proposed rule (1/8/01) Current Good Manufacturing Practice for Manufacturers of Cellular and Tissue-Based Products 4)FDA's draft guidance (6/25/02) Preventive Measures to Reduce the Possible Risk of CJD and vCJD by Human Cells, Tissues and Cellular and Tissue Based-Products. 5)FDA's final rule (5/25/04) Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). 6) FDA's draft guidance for industry (5/25/04) Eligibility Determination for Donors of Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/Ps). 7)FDA's final rule (11/24/04) Current Good Practice for Human Cells, Tissues, and Cellular and Tissue-Based Product Establishments, Inspection and Enforcement. 8)P.L108-216, the "Organ Donation and Recovery and Improvement Act," implementation by DHHS. 9)S.1479, the "Safe Tissue Act," entire bill. 10)H.R.2731, the "Safe Tissue Act," entire bill. 11)Tissue Education Initiative; assess perception of tissue community and congressional interest. 12)S.1062, William H. Frist Gift of Life Congressional Medal Act of 2007, entire bill. 13)H.R.1764, William H. Frist Gift of Life Congressional Medal Act of 2007, entire bill. 14)Department of Health adn Human Services, Advisory Committee on Organ Transplantation, jurisdictional questions, tissue-related input. 15)Department of Health and Human Services, Blood Products Advisory Committee, Issues related to tissue and disease transmission. 16) Department of Health and Human Services, Advisory Committee on Blood Safety and Availability, Issues related to tissue and disease transmission. 17)FDA Final Guidance Document (2/27/07), Eligibility Determination for Donors of Human Cells, Tissues and Cellular Tissue-Based Products (HCT/Ps). 18)Food and Drug Administration, Human Tissue Task Force, "Report of the Human Tissue Task Force", June 17, 2007, entire report. 1)Ongoing discussions with FDA officials; response to FDA's proposed regulation of Cellular and Tissue-Based Products (12/28/97) and proposed regulation thereto. 2)FDA's proposed rule (9/30/99) Suitability Determination of Cellular and Tissue-Basd Products
Client expense: — · Firm income: $20,000
Matched citations: H.R.1764
Safe Tissue Act
2007 · mid_year · Firm: JEFFERSON GOVERNMENT RELATIONS, L.L.C.
3)FDA's proposed rule (1/8/01) Current Good Manufacturing Practice for Manufacturers of Cellular and Tissue-Based Products 4)FDA's draft guidance (6/25/02) Preventive Measures to Reduce the Possible Risk of CJD and vCJD by Human Cells, Tissues and Cellular and Tissue Based-Products. 5)FDA's final rule (5/25/04) Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). 6) FDA's draft guidance for industry (5/25/04) Eligibility Determination for Donors of Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/Ps). 7)FDA's final rule (11/24/04) Current Good Practice for Human Cells, Tissues, and Cellular and Tissue-Based Product Establishments, Inspection and Enforcement. 8)P.L108-216, the "Organ Donation and Recovery and Improvement Act," implementation by DHHS. 9)S.1479, the "Safe Tissue Act," entire bill. 10)H.R.2731, the "Safe Tissue Act," entire bill. 11)Tissue Education Initiative; assess perception of tissue community and congressional interest. 12)S.1062, William H. Frist Gift of Life Congressional Medal Act of 2007, entire bill. 13)H.R.1764, William H. Frist Gift of Life Congressional Medal Act of 2007, entire bill. 14)Department of Health adn Human Services, Advisory Committee on Organ Transplantation, jurisdictional questions, tissue-related input. 15)Department of Health and Human Services, Blood Products Advisory Committee, Issues related to tissue and disease transmission. 16) Department of Health and Human Services, Advisory Committee on Blood Safety and Availability, Issues related to tissue and disease transmission. 17)FDA Final Guidance Document (2/27/07), Eligibility Determination for Donors of Human Cells, Tissues and Cellular Tissue-Based Products (HCT/Ps). 18)Food and Drug Administration, Human Tissue Task Force, "Report of the Human Tissue Task Force", June 17, 2007, entire report. 1)Ongoing discussions with FDA officials; response to FDA's proposed regulation of Cellular and Tissue-Based Products (12/28/97) and proposed regulation thereto. 2)FDA's proposed rule (9/30/99) Suitability Determination of Cellular and Tissue-Basd Products
Client expense: — · Firm income: $20,000
Matched citations: H.R.2731
William H. Frist Gift of Life Congressional Medal Act
2007 · mid_year · Firm: JEFFERSON GOVERNMENT RELATIONS, L.L.C.
3)FDA's proposed rule (1/8/01) Current Good Manufacturing Practice for Manufacturers of Cellular and Tissue-Based Products 4)FDA's draft guidance (6/25/02) Preventive Measures to Reduce the Possible Risk of CJD and vCJD by Human Cells, Tissues and Cellular and Tissue Based-Products. 5)FDA's final rule (5/25/04) Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). 6) FDA's draft guidance for industry (5/25/04) Eligibility Determination for Donors of Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/Ps). 7)FDA's final rule (11/24/04) Current Good Practice for Human Cells, Tissues, and Cellular and Tissue-Based Product Establishments, Inspection and Enforcement. 8)P.L108-216, the "Organ Donation and Recovery and Improvement Act," implementation by DHHS. 9)S.1479, the "Safe Tissue Act," entire bill. 10)H.R.2731, the "Safe Tissue Act," entire bill. 11)Tissue Education Initiative; assess perception of tissue community and congressional interest. 12)S.1062, William H. Frist Gift of Life Congressional Medal Act of 2007, entire bill. 13)H.R.1764, William H. Frist Gift of Life Congressional Medal Act of 2007, entire bill. 14)Department of Health adn Human Services, Advisory Committee on Organ Transplantation, jurisdictional questions, tissue-related input. 15)Department of Health and Human Services, Blood Products Advisory Committee, Issues related to tissue and disease transmission. 16) Department of Health and Human Services, Advisory Committee on Blood Safety and Availability, Issues related to tissue and disease transmission. 17)FDA Final Guidance Document (2/27/07), Eligibility Determination for Donors of Human Cells, Tissues and Cellular Tissue-Based Products (HCT/Ps). 18)Food and Drug Administration, Human Tissue Task Force, "Report of the Human Tissue Task Force", June 17, 2007, entire report. 1)Ongoing discussions with FDA officials; response to FDA's proposed regulation of Cellular and Tissue-Based Products (12/28/97) and proposed regulation thereto. 2)FDA's proposed rule (9/30/99) Suitability Determination of Cellular and Tissue-Basd Products
Client expense: — · Firm income: $20,000
Matched citations: S.1062
3)FDA's proposed rule (1/8/01) Current Good Manufacturing Practice for Manufacturers of Cellular and Tissue-Based Products 4)FDA's draft guidance (6/25/02) Preventive Measures to Reduce the Possible Risk of CJD and vCJD by Human Cells, Tissues and Cellular and Tissue Based-Products. 5)FDA's final rule (5/25/04) Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). 6) FDA's draft guidance for industry (5/25/04) Eligibility Determination for Donors of Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/Ps). 7)FDA's final rule (11/24/04) Current Good Practice for Human Cells, Tissues, and Cellular and Tissue-Based Product Establishments, Inspection and Enforcement. 8)P.L108-216, the "Organ Donation and Recovery and Improvement Act," implementation by DHHS. 9)S.1479, the "Safe Tissue Act," entire bill. 10)H.R.2731, the "Safe Tissue Act," entire bill. 11)Tissue Education Initiative; assess perception of tissue community and congressional interest. 12)S.1062, William H. Frist Gift of Life Congressional Medal Act of 2007, entire bill. 13)H.R.1764, William H. Frist Gift of Life Congressional Medal Act of 2007, entire bill. 14)Department of Health adn Human Services, Advisory Committee on Organ Transplantation, jurisdictional questions, tissue-related input. 15)Department of Health and Human Services, Blood Products Advisory Committee, Issues related to tissue and disease transmission. 16) Department of Health and Human Services, Advisory Committee on Blood Safety and Availability, Issues related to tissue and disease transmission. 17)FDA Final Guidance Document (2/27/07), Eligibility Determination for Donors of Human Cells, Tissues and Cellular Tissue-Based Products (HCT/Ps). 18)Food and Drug Administration, Human Tissue Task Force, "Report of the Human Tissue Task Force", June 17, 2007, entire report. 1)Ongoing discussions with FDA officials; response to FDA's proposed regulation of Cellular and Tissue-Based Products (12/28/97) and proposed regulation thereto. 2)FDA's proposed rule (9/30/99) Suitability Determination of Cellular and Tissue-Basd Products
Client expense: — · Firm income: $20,000
Matched citations: S.1479
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008
2007 · mid_year · Firm: JEFFERSON GOVERNMENT RELATIONS, L.L.C.
H.R. 3043, Making Appropriations for the Department of Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2008, provisions related to funding HRSA and programs on organ donation. S.1710, Same title as above.
Client expense: — · Firm income: $20,000
Matched citations: S.1710
To authorize the duration of the base contract of the Navy-Marine Corps Intranet contract to be more than five years but not more than seven years.
2006 · year_end · Firm: JEFFERSON GOVERNMENT RELATIONS, L.L.C.
S.3708, Making Appropriations for the Department of Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 20, 2007; provisions related to funding HRSA and programs on organ donation. H.R. 5647, Making Appropriations for the Department of Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2007; provisions related to funding HRSA and programs on organ donation.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 5647
Veterans Health Care Act of 2005
2006 · year_end · Firm: JEFFERSON GOVERNMENT RELATIONS, L.L.C.
S. 1182, the Veterans' Health Care Act of 2005; Section 9; Disclosure of Medical Records for the purpose of organ, eye and tissue donation. S.3421, the Veterans' Benefits, Health Care and Information Technology Act of 2006
Client expense: — · Firm income: $20,000
Matched citations: S. 1182
3. FDA's proposed rule (1/08/01) Current Good Manufacturing Practice for Manufacturers of Cellular and Tissue-Based Products. 4. FDA's draft guidance (6/25/02) Preventive Measures to Reduce the Possible Risk of CJD and and vDJD by Human Cells, Tissues and Cellular and Tissue-Based Products 5. FDA's final rule (5/25/04) Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) 6. FDA's draft guidance for industry (5/25/04) Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) 7. FDA's final rule (11/24/04) Current Good Tissue Practice for Human Cells, Tissues, and Cellular and Tissue-Based Product Establishments; Inspection and Enforcement 8. P.L. 108-216, the "Organ Donation and Recovery and Improvement Act;" implementation by DHHS. 9. S.2609, the "Safe Tissue Act" entire bill 10. H.R. 5209, the Safe Tissue Act", entire bill. 11. FDA Federal Register (12/4/06); Proposed Collection; Comment Request; Human Tissue Intended for Transplantation. 1. Ongoing discussions with FDA officials; response to FDA's proposed regulation of Cellular and Tissue-Based Products (12/28/97) and proposed regulation thereto. 2. FDA's proposed rule (9/30/99) Suitability Determination of Cellular and Tissue-Based Products.
Client expense: — · Firm income: $20,000
Matched citations: S.2609
Veterans Benefits, Health Care, and Information Technology Act of 2006
2006 · year_end · Firm: JEFFERSON GOVERNMENT RELATIONS, L.L.C.
S. 1182, the Veterans' Health Care Act of 2005; Section 9; Disclosure of Medical Records for the purpose of organ, eye and tissue donation. S.3421, the Veterans' Benefits, Health Care and Information Technology Act of 2006
Client expense: — · Firm income: $20,000
Matched citations: S.3421
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007
2006 · year_end · Firm: JEFFERSON GOVERNMENT RELATIONS, L.L.C.
S.3708, Making Appropriations for the Department of Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 20, 2007; provisions related to funding HRSA and programs on organ donation. H.R. 5647, Making Appropriations for the Department of Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2007; provisions related to funding HRSA and programs on organ donation.
Client expense: — · Firm income: $20,000
Matched citations: S.3708
Source: Senate LDA